Clover Health Investments (CLOV) Net Cash Flow (2020 - 2026)

Clover Health Investments' Net Cash Flow history runs 7 years deep, the most recent figure standing at $95.0 million for Q1 2026.

• Quarterly Net Cash Flow rose 342.85% year-over-year to $95.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.8 million (up 442.08% YoY) and the FY2025 annual result came in at -$116.2 million, down 277.05% from the prior year.
• Net Cash Flow was $95.0 million for Q1 2026 at Clover Health Investments, up from -$111.8 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $119.5 million in Q2 2023 and bottomed at -$196.7 million in Q4 2022.
• A 5-year average of -$4.7 million and a median of $31.8 million in 2024 frame the typical range for Net Cash Flow.
• Annual changes were most pronounced in 2022 — Net Cash Flow slumped 301.28% — and 2023, when it surged 433.16%.
• Clover Health Investments' Net Cash Flow stood at -$196.7 million in 2022, then rose by 10.88% to -$175.2 million in 2023, then surged by 68.81% to -$54.7 million in 2024, then tumbled by 104.42% to -$111.8 million in 2025, then jumped by 184.98% to $95.0 million in 2026.
• Business Quant data shows CLOV's Net Cash Flow at $95.0 million in Q1 2026, -$111.8 million in Q4 2025, and $1.4 million in Q3 2025.